Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

Articles published in
Mycoses
    June 2024
  1. DENG R, Chen X, Zheng D, Xiao Y, et al
    Epidemiologic features and therapeutic strategies of kerion: A nationwide multicentre study.
    Mycoses. 2024;67:e13751.
    >> Share

    May 2024
  2. MILANEZ EPR, de Souza PFSM, Monteiro RC, Pereira LMG, et al
    Fusarium keratitis in a Brazilian tropical semi-arid area: Clinical-epidemiological features, molecular identification and antifungal susceptibility.
    Mycoses. 2024;67:e13728.
    >> Share

  3. LEE HG, Bok EY, Jung YH, Hur TY, et al
    Antifungal activity of aminopyrrolnitrin against Trichophyton verrucosum in a guinea pig model of dermatophytosis.
    Mycoses. 2024;67:e13748.
    >> Share

    April 2024
  4. UHRLASS S, Mey S, Koch D, Mutze H, et al
    Dermatophytes and skin dermatophytoses in Southeast Asia-First epidemiological survey from Cambodia.
    Mycoses. 2024;67:e13718.
    >> Share

  5. WANG S, Chen W, Liu F, Li R, et al
    Comparison of dermoscopic characteristics on toenail onychomycosis in psoriatic and non-psoriatic patients: A prospective study.
    Mycoses. 2024;67:e13721.
    >> Share

  6. CONSUEGRA-ASPRILLA JM, Rodriguez-Echeverri C, Posada DH, Gomez BL, et al
    Patients with recurrent vulvovaginal candidiasis exhibit a decrease in both the fungicidal activity of neutrophils and the proliferation of peripheral blood mononuclear cells.
    Mycoses. 2024;67:e13720.
    >> Share

  7. QU Y, Feng Y, Bian S, Yang Y, et al
    Low toxicity contributes to Sporothrix globosa invade the skin of patients in low-epidemic areas of China.
    Mycoses. 2024;67:e13724.
    >> Share

  8. GUPTA AK, Wang T, Polla Ravi S, Mann A, et al
    Global prevalence of onychomycosis in general and special populations: An updated perspective.
    Mycoses. 2024;67:e13725.
    >> Share

    March 2024
  9. SCHALLER M, Walker B, Nabhani S, Odon A, et al
    Activity of amorolfine or ciclopirox in combination with terbinafine against pathogenic fungi in onychomycosis-Results of an in vitro investigation.
    Mycoses. 2024;67:e13710.
    >> Share

  10. DANTAS MDS, Cintra MEC, Lucini F, Venturini J, et al
    CARD9 mutations in patients with fungal infections: An update from the last 5 years.
    Mycoses. 2024;67:e13712.
    >> Share

  11. ZANG F, Wang Z, Yang Y, Xiao Z, et al
    Responses of keratinocytes to Trichophyton mentagrophyte infection based on whole transcriptome analysis.
    Mycoses. 2024;67:e13713.
    >> Share

  12. BHAT RM, Madhumita M, Marla NJ, Jayaraman J, et al
    Immunohistochemical analysis of chronic and recurrent dermatophytosis.
    Mycoses. 2024;67:e13714.
    >> Share

    February 2024
  13. DE OLIVEIRA VF, Petrucci JF, Taborda M, Brener PZ, et al
    Clinical characteristics, diagnosis, and treatment of central nervous system sporotrichosis: Systematic review and meta-analysis.
    Mycoses. 2024;67:e13697.
    >> Share

  14. PARIHAR R, Singh U, Das A, Baishya B, et al
    Identification of primary metabolites in fungal species of Trichophyton mentagrophyte and Trichophyton rubrum by NMR spectroscopy.
    Mycoses. 2024;67:e13699.
    >> Share

  15. BALASUBRAMANIAN A, Akbar Ali NA, Pugazhenthi A, Gopalan K, et al
    A clinical prevalence of dermatophytic mycoses with an assessment of its clinical manifestations in a tertiary care hospital at Salem, South India.
    Mycoses. 2024;67:e13707.
    >> Share

  16. NOKDHES YN, Leeyaphan C, Jirawattanadon P, Pongkittilar B, et al
    Prevalence and characteristics of Epidermophyton floccosum skin infections: A 12-year retrospective study.
    Mycoses. 2024;67:e13702.
    >> Share

    January 2024
  17. JEON JJ, Kim YH, Lim SH, Lee S, et al
    Comparing the diagnostic accuracy of PCR-reverse blot hybridization assay and conventional fungus study in superficial fungal infection of the skin: A systematic review.
    Mycoses. 2024;67:e13678.
    >> Share

  18. LUO Y, Tang JF, Gao FF, Quan JH, et al
    NLRP3 regulates CIITA/MHC II axis and interferon-gamma-inducible chemokines in Malassezia globosa-infected keratinocytes.
    Mycoses. 2024;67:e13680.
    >> Share

  19. GUPTA AK, Elewski B, Joseph WS, Lipner SR, et al
    Treatment of onychomycosis in an era of antifungal resistance: Role for antifungal stewardship and topical antifungal agents.
    Mycoses. 2024;67:e13683.
    >> Share

  20. RANA DK, Shah TS, Rohit MH, Patel NH, et al
    Evaluation of the benefit of the addition of 1% topical luliconazole versus topical bland emollient to the systemic itraconazole therapy for the management of disseminated dermatophytosis: A randomised control trial.
    Mycoses. 2024;67:e13681.
    >> Share

  21. NAVARRO-PEREZ D, Garcia-Oreja S, Tardaguila-Garcia A, Leon-Herce D, et al
    Inter-observer reliability of the Onychomycosis Severity Index depending on clinical experience: A review of 50 cases.
    Mycoses. 2024;67:e13694.
    >> Share

  22. IBRAHIM AM, Ibrahim NS, Elgharabawy ES, Morsi HM, et al
    Efficacy of topical trichloroacetic acid 100% either alone or combined with topical tioconazole 28% versus systemic itraconazole in the treatment of onychomycosis.
    Mycoses. 2024;67:e13690.
    >> Share

  23. CHIRIAC A, Diaconeasa A, Voicu C, Ivaniciuc M, et al
    Kerion Celsi in infants and children-A narrative review 2010-2023.
    Mycoses. 2024;67:e13675.
    >> Share

  24. STARACE M, Milan E, Summa G, Alessandrini AM, et al
    Onychoscopic characteristics of Trichophyton rubrum and Trichophyton interdigitalis fungal infections: A multicentric study.
    Mycoses. 2024;67:e13673.
    >> Share

  25. FAELI L, Kermani F, Rezaei-Matehkolaei A, Ilkit M, et al
    Molecular typing of a collection of Iranian clinical Trichophyton tonsurans isolates based on the non-transcribed spacer region of rDNA and antifungal susceptibility testing of the species.
    Mycoses. 2024;67:e13666.
    >> Share

  26. GUERRERO-PONCE AE, Araiza J, Tirado-Sanchez A, Bonifaz A, et al
    Review Article White Piedra: Review of 131 cases.
    Mycoses. 2024;67:e13668.
    >> Share

  27. LIU YY, Song Y, Guan MQ, Yang L, et al
    Hyperthermia is a promising potential adjunct to treating sporotrichosis: A refractory case of HIV sporotrichosis and in vitro experiments on Sporothrix spp.
    Mycoses. 2024;67:e13671.
    >> Share

  28. SONG G, Kong X, Li X, Liu W, et al
    Prior selection of itraconazole in the treatment of recalcitrant Trichophyton indotineae infection: Real-world results from retrospective analysis.
    Mycoses. 2024;67:e13663.
    >> Share

  29. NYUYKONGE B, Siddig EE, Nyaoke BA, Zijlstra EE, et al
    Using (1,3)-beta-D-glucan concentrations in serum to monitor the response of azole therapy in patients with eumycetoma caused by Madurella mycetomatis.
    Mycoses. 2024;67:e13664.
    >> Share

  30. RAMZY B, Emily AH, Jiryis B, Ziad K, et al
    Nd:YAG 1064 nm laser treatment for onychomycosis - is it really effective? A prospective assessment for efficiency and factors contributing to response.
    Mycoses. 2024;67:e13657.
    >> Share

  31. GOMEZ C, Schuele G, Alberdi E
    Medium-term antifungal effects of methylene blue versus flavin mononucleotide in the treatment of moderate toenail onychomycosis.
    Mycoses. 2024;67:e13661.
    >> Share

  32. ROSTER K, Wang Y, Lipner SR
    Retrospective analysis of onychomycosis prescribing patterns using the medicare part D prescribers database 2016-2020.
    Mycoses. 2024;67:e13660.
    >> Share

  33. PATHANIA YS, Cds K, Kumar A
    Comparing emollient use with topical luliconazole (azole) in the maintenance of remission of chronic and recurrent dermatophytosis. An open-label, randomized prospective active-controlled non-inferiority study.
    Mycoses. 2024;67:e13659.
    >> Share

  34. MAGALHAES VCR, Colombo SA, Peres NTA, Moura AS, et al
    Clinical factors associated with systemic sporotrichosis in Brazil.
    Mycoses. 2024;67:e13656.
    >> Share

  35. HAGHANI I, Hedayati MT, Shokohi T, Kermani F, et al
    Onychomycosis due to Fusarium species in different continents, literature review on diagnosis and treatment.
    Mycoses. 2024;67:e13652.
    >> Share

  36. BOMBASSARO A, Figueiredo JM, Taborda CP, Joosten LAB, et al
    Skin innate immune response against fungal infections and the potential role of trained immunity.
    Mycoses. 2024;67.
    >> Share

    December 2023
  37. KASSEM R, Barzilai A, Baum S, Kempfner A, et al
    Improved effectiveness of an increased dose of griseofulvin for treating Tinea capitis among refugee children in Israel: A retrospective cohort study.
    Mycoses. 2023;66:1064-1070.
    >> Share

  38. LEHRER S, Rheinstein PH
    Association of Kallikrein Related Peptidase 3 (KLK3) gene with dermatophytosis in the UK biobank cohort.
    Mycoses. 2023;66:1050-1055.
    >> Share

  39. NAVARRO-PEREZ D, Garcia-Oreja S, Tardaguila-Garcia A, Leon-Herce D, et al
    Microbiological culture combined with PCR for the diagnosis of onychomycosis: Descriptive analysis of 121 patients.
    Mycoses. 2023;66:1045-1049.
    >> Share

    November 2023
  40. BORBA OSM, Ogawa MM, Kirsztajn GM, Tomimori J, et al
    Onychomycosis in immunocompromised population: Phenotypic and molecular identification.
    Mycoses. 2023;66:1018-1024.
    >> Share

    October 2023
  41. COLOMBO SA, Bicalho GC, de Oliveira CSF, de Magalhaes Soares DF, et al
    Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease.
    Mycoses. 2023;66:911-922.
    >> Share

  42. DA COSTA B, Pippi B, Merkel S, Agostinetto G, et al
    Drosophila melanogaster as a model of systemic dermatophytosis.
    Mycoses. 2023;66:906-910.
    >> Share

  43. POESTER VR, Munhoz LS, Stevens DA, Melo AM, et al
    Nikkomycin Z for the treatment of experimental sporotrichosis caused by Sporothrix brasiliensis.
    Mycoses. 2023;66:898-905.
    >> Share

  44. TAIBO A, Seoane Estevez A, Martinez Campayo N, Rodriguez Mayo M, et al
    Emerging subcutaneous mycoses by opportunistic filamentous fungi: A retrospective study in Northwest Spain.
    Mycoses. 2023;66:891-897.
    >> Share

  45. UEMURA EVG, Rossato L
    Sporotrichosis co-infection with human immunodeficiency virus/acquired immunodeficiency syndrome.
    Mycoses. 2023;66:845-853.
    >> Share

  46. FULGENCE KK, Marie KPC, Akoua VB, Massafoma KEG, et al
    Dermatophytosis and the associated risk factors among primary school children in southern and central Cote d'Ivoire.
    Mycoses. 2023;66:869-875.
    >> Share

  47. DEV PP, Bansal S, Bhargava A
    Revisiting the pathogenesis of dermatophytosis: A cross-sectional analytic study of serum levels of interleukins-2, 8, 10 and 17.
    Mycoses. 2023;66:876-881.
    >> Share

    September 2023
  48. LIETZ A, Eckel F, Kiss H, Noe-Letschnig M, et al
    Quality of life in women with chronic recurrent vulvovaginal candidosis: A sub-analysis of the prospective multicentre phase IIb/III Prof-001 study.
    Mycoses. 2023;66:767-773.
    >> Share

    August 2023
  49. DE FREITAS VLT, Rocha FMM, Ribeiro EN, Lindoso JAL, et al
    Seasonality of sporotrichosis in Brazil: A modelled analysis of the epidemic in Sao Paulo, 2011-2020.
    Mycoses. 2023;66:643-650.
    >> Share

  50. LIN L, Huang J, Fang J, Li J, et al
    Prevalence and Antifungal Susceptibility of Sporothrix species in Guangzhou, Southern China.
    Mycoses. 2023;66:651-658.
    >> Share

  51. MOHOREA-NEATA AL, Ghita MC, Moroti R, Ghiaur A, et al
    Invasive fusariosis in acute leukaemia patients-An outbreak in the haematology ward.
    Mycoses. 2023;66:705-710.
    >> Share

    July 2023
  52. BOMBASSARO A, Spruijtenburg B, Medeiros F, Jacomel Favoreto de Souza Lima B, et al
    Genotyping and antifungal susceptibility testing of Sporothrix brasiliensis isolates from Southern Brazil.
    Mycoses. 2023;66:585-593.
    >> Share

  53. ZALACAIN-VICUNA AJ, Nieto C, Picas J, Martinez H, et al
    Efficacy and safety of a new medicated nail hydrolacquer in the treatment of adults with toenail onychomycosis: A randomised clinical trial.
    Mycoses. 2023;66:566-575.
    >> Share

    June 2023
  54. THAMMASIT P, Laliam A, Chaicumpar K, Pruksaphon K, et al
    Differential lipase virulence in Malassezia furfur dimorphism isolated from pityriasis versicolor patients and healthy individuals.
    Mycoses. 2023;66:540-549.
    >> Share

  55. NAVARRO-PEREZ D, Tardaguila-Garcia A, Garcia-Oreja S, Lopez-Moral M, et al
    Onychomycosis associated with diabetic foot syndrome: A systematic review.
    Mycoses. 2023;66:459-466.
    >> Share

  56. LEEYAPHAN C, Chai-Adisaksopha C, Tovanabutra N, Phinyo P, et al
    Prognostic factors for mycological cure in patients with onychomycosis caused by Neoscytalidium dimidiatum: A retrospective cohort study.
    Mycoses. 2023;66:497-504.
    >> Share

  57. SIDDIG EE, Ahmed A, Hassan OB, Bakhiet SM, et al
    Using a Madurella mycetomatis-specific PCR on grains obtained via non-invasive fine-needle aspirated material is more accurate than cytology.
    Mycoses. 2023;66:477-482.
    >> Share

    May 2023
  58. WEI W, He X, Bao X, Wang G, et al
    Application of deep learning algorithm in the recognition of cryptococcosis and talaromycosis skin lesions.
    Mycoses. 2023 May 3. doi: 10.1111/myc.13598.
    >> Share

  59. SONG G, Zhang M, Liu W, Liang G, et al
    Children onychomycosis, a neglected dermatophytosis: A retrospective study of epidemiology and treatment.
    Mycoses. 2023;66:448-454.
    >> Share

  60. FIRKUS D, Abu Saleh OM, Enzler MJ, Jannetto PJ, et al
    Does metabolite matter? Defining target itraconazole and hydroxy-itraconazole serum concentrations for blastomycosis.
    Mycoses. 2023;66:412-419.
    >> Share

  61. PILZ JF, Koberle M, Kain A, Seidl P, et al
    Increasing incidence of Trichophyton tonsurans in Munich-A single-centre observation.
    Mycoses. 2023;66:441-447.
    >> Share

  62. SIDDIG EE, Nyuykonge B, Mhmoud NA, Abdallah OB, et al
    Comparing the performance of the common used eumycetoma diagnostic tests.
    Mycoses. 2023;66:420-429.
    >> Share

    April 2023
  63. ZHU H, Xia X, Zhi H, Shen H, et al
    Retrospective analysis of 71 patients with cutaneous sporotrichosis.
    Mycoses. 2023 Apr 10. doi: 10.1111/myc.13588.
    >> Share

  64. BHAT RM, Madhumita M, Jayaraman J
    Dermatophytoses Severity Score - A novel point-of-care scoring tool to assess the severity of dermatophytosis.
    Mycoses. 2023;66:354-361.
    >> Share

  65. ZHOU X, Liu W, Yang S, Wu A, et al
    Exploring the clinical features and risk factors for children tinea capitis complicated with allergic diseases.
    Mycoses. 2023;66:338-345.
    >> Share

  66. BHALAVI H, Shaw D, Mehta H, Narang T, et al
    Correlation of plasma levels of itraconazole with treatment response at 4 weeks in chronic dermatophytosis: Results of a randomised controlled trial.
    Mycoses. 2023;66:281-288.
    >> Share

    March 2023
  67. NOSRATABADI M, Faeli L, Haghani I, Mohammadi R, et al
    In vitro antifungal susceptibility profile of Iranian Fusarium isolates: Emphasising on the potent inhibitory effect of efinaconazole compared to other drugs.
    Mycoses. 2023;66:258-275.
    >> Share

  68. PARK H, Bae S, Kim MJ, Chong YP, et al
    Clinical characteristics and outcomes of invasive and non-invasive fusariosis in South Korea.
    Mycoses. 2023;66:211-218.
    >> Share

    February 2023
  69. FERREIRA VOIDALESKI M, de Fatima Costa F, de Hoog GS, Gomes RR, et al
    Metagenomics reveals an abundance of black yeast-like fungi in the skin microbiome.
    Mycoses. 2023 Feb 5. doi: 10.1111/myc.13574.
    >> Share

  70. GALILI E, Goldsmith T, Khanimov I, Arbel C, et al
    Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response.
    Mycoses. 2023;66:144-149.
    >> Share

    January 2023
  71. BATVANDI A, Pchelin IM, Kiasat N, Kharazi M, et al
    Time and cost-efficient identification of Trichophyton indotineae.
    Mycoses. 2023;66:75-81.
    >> Share

  72. MOSELEY I, Ragi SD, Ouellette S, Rao B, et al
    Tinea pedis in underrepresented groups: All of Us database analysis.
    Mycoses. 2023;66:29-34.
    >> Share

    December 2022
  73. NYUYKONGE B, Siddig EE, Mhmoud NA, Nyaoke BA, et al
    Epidemiological cut-off values for itraconazole and ravuconazole for Madurella mycetomatis, the most common causative agent of mycetoma.
    Mycoses. 2022;65:1170-1178.
    >> Share

  74. KHATTAB F, Elkholy BM, Taha M, Abd-Elbaset A, et al
    Voriconazole is superior to combined itraconazole/isotretinoin therapy and itraconazole monotherapy in recalcitrant dermatophytosis.
    Mycoses. 2022;65:1194-1201.
    >> Share

  75. KOCH C, Nordzieke S, Grieger J, Mayser P, et al
    Medium-chain fatty acid esters are effective even in azole-resistant Malassezia pachydermatis.
    Mycoses. 2022;65:1188-1193.
    >> Share

  76. GUEVARA A, Nery AF, de Souza Carvalho Melhem M, Bonfietti L, et al
    Molecular epidemiology and clinical-laboratory aspects of chromoblastomycosis in Mato Grosso, Brazil.
    Mycoses. 2022;65:1146-1158.
    >> Share

  77. DI VITO M, Scafuro C, Mariotti M, Garzoli S, et al
    Green natural nail polish modified with essential oils to treat onychomycosis.
    Mycoses. 2022;65:1127-1136.
    >> Share

  78. YILMAZ A, Goktay F, Varol R, Gencoglan G, et al
    Deep convolutional neural networks for onychomycosis detection using microscopic images with KOH examination.
    Mycoses. 2022;65:1119-1126.
    >> Share

  79. MUNHOZ LS, Poester VR, Severo CB, Trapaga MR, et al
    Update of the Epidemiology of the Sporotrichosis Epidemic in the state of Rio Grande do Sul, Brazil.
    Mycoses. 2022;65:1112-1118.
    >> Share

    November 2022
  80. HAGHANI I, Shams-Ghahfarokhi M, Dalimi Asl A, Shokohi T, et al
    Prevalence, genetic diversity and antifungal susceptibility profiles of F. fujikuroi, F. solani and Fusarium incarnatum-equiseti species complexes from onychomycosis in north of Iran.
    Mycoses. 2022;65:1030-1039.
    >> Share

    October 2022
  81. COGNIALLI R, Bloss K, Weiss I, Caceres DH, et al
    A lateral flow assay for the immunodiagnosis of human cat-transmitted sporotrichosis.
    Mycoses. 2022;65:926-934.
    >> Share

  82. NIODE NJ, Suling PL, Adji A, Miranda E, et al
    Clinico-laboratory findings of Malassezia folliculitis in Indonesia: A multicentre study.
    Mycoses. 2022;65:953-959.
    >> Share

  83. DE OLIVEIRA GV, Maia MLP, Leao FAA, Sad EF, et al
    What to expect when AGEP is induced by terbinafine? Case report and critical review of the literature.
    Mycoses. 2022;65:918-925.
    >> Share

  84. XIA H, Mo XH, Yang LJ, Yang H, et al
    Comparison of samples of blister fluid and scales in the diagnosis of dermatomycosis.
    Mycoses. 2022;65:969-975.
    >> Share

    September 2022
  85. PATEL N, Padhiyar J, Singh R, Bloch A, et al
    Comparative evaluation of host immune response and cytokine signature pertaining to Th1 and Th2 immune arms in serum and tissue among patients of acute localised vs. chronic disseminated dermatophytosis.
    Mycoses. 2022;65:877-886.
    >> Share

    July 2022
  86. POWELL J, Porter E, Field S, O'Connell NH, et al
    Epidemiology of dermatomycoses and onychomycoses in Ireland (2001-2020): A single-institution review.
    Mycoses. 2022;65:770-779.
    >> Share

  87. SKAASTRUP KN, Astvad KMT, Arendrup MC, Jemec GBE, et al
    Disinfection trials with terbinafine-susceptible and terbinafine-resistant dermatophytes.
    Mycoses. 2022;65:741-746.
    >> Share

    June 2022
  88. RONG T, Zhu P, Zhou Y, Li Q, et al
    Altered skin fungal and bacterial community compositions in tinea capitis.
    Mycoses. 2022 Jun 11. doi: 10.1111/myc.13480.
    >> Share

  89. EGGER M, Hoenigl M, Thompson GR 3rd, Carvalho A, et al
    Let's talk about sex characteristics-As a risk factor for invasive fungal diseases.
    Mycoses. 2022;65:599-612.
    >> Share

  90. FUHR R, Cook D, Ridden J, Nield K, et al
    Results from a Phase 1/2 trial of BB2603, a terbinafine-based topical nano-formulation, in onychomycosis and tinea pedis.
    Mycoses. 2022;65:661-669.
    >> Share

  91. NYUYKONGE B, Lim W, van Amelsvoort L, Bonifaz A, et al
    Eumycetoma causative agents are inhibited in vitro by luliconazole, lanoconazole and ravuconazole.
    Mycoses. 2022;65:650-655.
    >> Share

    May 2022
  92. ZIAKA M, Papakonstantinou E, Vasileiou E, Chorafa E, et al
    Pediatric cutaneous mucormycosis: case report and review of the literature.
    Mycoses. 2022 May 5. doi: 10.1111/myc.13452.
    >> Share

  93. ATSU N, Ergin C, Caf N, Turkoglu Z, et al
    Effectiveness of FastFung agar in the isolation of Malassezia furfur from skin samples.
    Mycoses. 2022 May 4. doi: 10.1111/myc.13450.
    >> Share

  94. CORREIA NS, Balbinot RTS, Bonacorsi C, Donofrio FC, et al
    Epidemiology of dermatomycoses in children in Northern Mato Grosso 2015-2020.
    Mycoses. 2022;65:560-566.
    >> Share

    April 2022
  95. ZHU X, Zheng B, Cai W, Zhang J, et al
    Deep learning-based diagnosis models for onychomycosis in dermoscopy.
    Mycoses. 2022;65:466-472.
    >> Share

  96. NASR M, Abd-Elhamid N, Abd-Allah D, Elkholy B, et al
    Acitretin: Could it be a new therapeutic player in the field of onychomycosis?
    Mycoses. 2022;65:402-410.
    >> Share

  97. SONG G, Zhang M, Liu W, Liang G, et al
    Changing face of epidemiology of dermatophytoses in Chinese Mainland: A 30 years nationwide retrospective study from 1991 to 2020.
    Mycoses. 2022;65:440-448.
    >> Share

  98. BLUME-PEYTAVI U, Tosti A, Falques M, Tamarit ML, et al
    A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
    Mycoses. 2022;65:392-401.
    >> Share

    March 2022
  99. WIDATY S, Oktarina C, Suling PL, Niode NJ, et al
    Mucocutaneous mycoses in people living with human immunodeficiency virus in Indonesia.
    Mycoses. 2022;65:323-330.
    >> Share

  100. TRAVE I, Cozzani E, Canepa P, Verdiani S, et al
    Real-life applicability of the Euroarray dermatomycosis kit in the diagnosis of onychomycosis.
    Mycoses. 2022;65:317-322.
    >> Share

    February 2022
  101. VILLACORTA CARI E, Leedy N, Ribes JA, Soria J, et al
    Risk factors of severe blastomycosis and comparison of diagnosis and outcomes between immunocompetent and immunocompromised patients.
    Mycoses. 2022;65:239-246.
    >> Share

    January 2022
  102. WANG S, Song Y, Wan Z, Chen W, et al
    Characterisation of the nail microbiome in psoriatic and nonpsoriatic patients with onychomycosis.
    Mycoses. 2022;65:35-44.
    >> Share

  103. POESTER VR, Stevens DA, Basso RP, Munhoz LS, et al
    CATastrophe: Response to the challenges of zoonotic sporotrichosis in southern Brazil.
    Mycoses. 2022;65:30-34.
    >> Share

  104. SHENOY MM, Rengasamy M, Dogra S, Kaur T, et al
    A multicentric clinical and epidemiological study of chronic and recurrent dermatophytosis in India.
    Mycoses. 2022;65:13-23.
    >> Share

    December 2021
  105. KHURANA A, Agarwal A, Singh A, Sardana K, et al
    Predicting a therapeutic cut-off serum level of itraconazole in recalcitrant tinea corporis and cruris-A prospective trial.
    Mycoses. 2021;64:1480-1488.
    >> Share

  106. LAROCHE L, Bourgeois N, Lachaud L, Rispail P, et al
    Epidemiological analysis of nail aspergillosis and non-dermatophyte moulds. Criteria for the involvement of Aspergillus in 102 cases of onychomycosis at Montpellier University Hospital, France (1991-2019).
    Mycoses. 2021;64:1546-1553.
    >> Share

  107. GUARANA M, Nouer SA, Nucci M
    EQUAL Fusariosis score 2021: An European Confederation of Medical Mycology score derived from current guidelines to measure QUALity of the clinical management of invasive fusariosis.
    Mycoses. 2021;64:1542-1545.
    >> Share

  108. HE M, Zeng J, Mao Y, Zheng Y, et al
    Aetiological changes of tinea capitis in the Hubei area in 60 years: Focus on adult tinea capitis.
    Mycoses. 2021;64:1527-1534.
    >> Share

    November 2021
  109. RONG T, Li R, Ruojun W
    Dysbiosis of Skin Mycobiome in Atopic Dermatitis.
    Mycoses. 2021 Nov 24. doi: 10.1111/myc.13402.
    >> Share

  110. ELSNER K, Holstein J, Hilke FJ, Blumenstock G, et al
    Prevalence of Candida species in Psoriasis.
    Mycoses. 2021 Nov 17. doi: 10.1111/myc.13399.
    >> Share

  111. ZHANG W, Wu S, Wang X, Gao Y, et al
    Malignant Transformation and Treatment Recommendations of Chronic Hyperplastic Candidiasis-A Six-year Retrospective Cohort Study.
    Mycoses. 2021;64:1422-1428.
    >> Share

  112. JHA K, Shaw D, Karim A, Narang T, et al
    Immunological response and clinical profile in patients with recurrent dermatophytosis.
    Mycoses. 2021;64:1429-1441.
    >> Share

  113. JAIN A, Dhamale S, Sardesai V
    Factors responsible for difficult to treat superficial fungal infections: A study from a tertiary healthcare centre in India.
    Mycoses. 2021;64:1442-1447.
    >> Share

  114. SHAMSIZADEH F, Ansari S, Zarei Mahmoudabadi A, Hubka V, et al
    In vitro antifungal susceptibility patterns of Trichophyton benhamiae complex isolates from diverse origin.
    Mycoses. 2021;64:1378-1386.
    >> Share

    October 2021
  115. SHARMA B, Nonzom S
    Novel cases of cutaneous phaeohyphomycosis by Alternaria alstromeriae, Epicoccum tritici and Phialemonium obovatum from North India.
    Mycoses. 2021 Oct 3. doi: 10.1111/myc.13378.
    >> Share

  116. NOWICKA D, Nawrot U
    Tinea pedis-An embarrassing problem for health and beauty-A narrative review.
    Mycoses. 2021;64:1140-1150.
    >> Share

  117. ZHAO Y, Gan M, Li L, Su H, et al
    Majocchi's granuloma: Autoinoculation and adaption of Trichophyton rubrum with molecular evidence.
    Mycoses. 2021;64:1272-1278.
    >> Share

    September 2021
  118. BADIANE AS, Diongue K, Seck MC, Ndiaye M, et al
    Epidemiological aspects of superficial fungal infections in Koranic schools in two localities of Senegal (Thies and Touba).
    Mycoses. 2021;64:1132-1136.
    >> Share

    August 2021
  119. METIN MS, Elmas OF, Demirbas A, Erel O, et al
    The role of oxidative stress in onychomycosis: Thiol/disulphide homeostasis.
    Mycoses. 2021;64:947-953.
    >> Share

  120. GNAT S, Dylag M, Lagowski D, Zielinski J, et al
    Therapeutic efficacy of topically used luliconazole vs. terbinafine 1% creams.
    Mycoses. 2021;64:967-975.
    >> Share

  121. SHAW D, Ghosh AK, Paul S, Singh S, et al
    Matrix-assisted laser desorption/ionisation-time of flight mass spectrometry: Protocol standardisation, comparison and database expansion for faster and reliable identification of dermatophytes.
    Mycoses. 2021;64:926-935.
    >> Share

  122. SHARMA B, Nonzom S
    Superficial mycoses, a matter of concern: Global and Indian scenario-an updated analysis.
    Mycoses. 2021;64:890-908.
    >> Share

  123. CHANG MJ, Qiu Y, Lipner SR
    Race reporting and representation in onychomycosis clinical trials: A systematic review.
    Mycoses. 2021;64:954-966.
    >> Share

    July 2021
  124. PHAM CVA, Rademacher F, Hinrichs H, Beck-Jendroschek V, et al
    Expression of epidermal antimicrobial peptides is increased in tinea pedis.
    Mycoses. 2021;64:763-770.
    >> Share

  125. DA COSTA B, Pippi B, Berlitz SJ, Carvalho AR, et al
    Evaluation of activity and toxicity of combining clioquinol with ciclopirox and terbinafine in alternative models of dermatophytosis.
    Mycoses. 2021;64:727-733.
    >> Share

  126. SINGH A, Singh P, Dingemans G, Meis JF, et al
    Evaluation of DermaGenius((R)) resistance real-time polymerase chain reaction for rapid detection of terbinafine-resistant Trichophyton species.
    Mycoses. 2021;64:721-726.
    >> Share

  127. ABDILLAH A, Packeu A, Khelaifia S, Ranque S, et al
    Intra- and inter-laboratory comparison of mDixon and FastFung broths for Malassezia antifungal susceptibility testing.
    Mycoses. 2021;64:716-720.
    >> Share

  128. BADALI H, Canete-Gibas C, Patterson H, Sanders C, et al
    In vitro activity of olorofim against clinical isolates of the Fusarium oxysporum and Fusarium solani species complexes.
    Mycoses. 2021;64:748-752.
    >> Share

  129. REINEL D
    Non-dermatophyte fungi in onychomycosis-Epidemiology and consequences for clinical practice.
    Mycoses. 2021;64:694-700.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016